The trademark SETARNA was filed by AReNA-Biotech GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on March 1, 2021, and received one opposition filed on May 13, 2021 by Serana Europe GmbH on Likelihood of confusion. the opponent was represented by BOESLING IP RECHTSANWÄLTE PARTG MBB and proceedings were handled in German, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 13, 2021
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Chemical preparations for use in dna analysis [other than medical]
Chemicals for use in industry and science
Nucleic acids for scientific purposes
Reagents for research purposes.
The mark was filed in class 5 with following description of goods:
RNA synthesis inhibitors
DNA synthesis inhibitors
Pharmaceuticals
Vaccines
Diagnostic reagents for medical use
Medicine
Chemical preparations for use in dna analysis [medical].
The mark was filed in class 42 with following description of goods:
DNA screening for scientific research purposes
Biological research, clinical research and medical research
Conducting clinical trials for pharmaceutical products
Analysis of human serum for medical research
Development of pharmaceutical preparations and medicines
Research and development of vaccines and medicines
Research in the field of pharmacogenetics
Research and development in the pharmaceutical and biotechnology fields
Scientific research and development
Biotechnological research relating to enzymatic synthesis
Research relating to biotechnology
Analysis in the field of molecular biology
Research and development services relating to vaccines
Research in the field of gene therapy
Clinical research
Biomedical research services.
The mark was filed in class 44 with following description of goods:
DNA screening for medical purposes
Medical screening
RNA or DNA analysis for cancer diagnosis and prognosis
Medical testing services relating to the diagnosis and treatment of disease
Medical services relating to the removal, treatment and processing of human cells
Medical and health services relating to DNA, genetics and genetic testing
Medical counseling
Pharmaceutical advice
Medical services relating to the removal, treatment and processing of stem cells.